# BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

> **NCT01156545** · PHASE2 · COMPLETED · sponsor: **National Cancer Center, Korea** · enrollment: 68 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** BIBW 2992
- **DRUG:** simvastatin

## Key facts

- **NCT ID:** NCT01156545
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2016-12-31
- **Final completion:** 2021-06-09
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2022-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01156545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01156545, "BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01156545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*